Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Motus Therapeutics, Inc. · Diabetes Mellitus · Diabetes Mellitus Complications
Phase 2
Completed
204
2016-09
Industry sponsor intelligence
Motus Therapeutics, Inc.Clinical Pipeline.
Lead-sponsor view of Motus Therapeutics, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 7
- Recruiting
- 0
- Active
- 0
- Completed
- 6
- Results posted
- 0
- Avg enrollment
- 49
Pipeline overview
Programs by phase and activity.
Velocity
Motus Therapeutics, Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
7phase labels
Early Phase 10
Phase 13
Phase 24
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Relamorelin → | 7 | 3 | 4 | 0 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa
Motus Therapeutics, Inc. · Anorexia Nervosa
Phase 2
Completed
20
2016-09
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
Motus Therapeutics, Inc. · Constipation
Phase 2
Completed
48
2016-09
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Motus Therapeutics, Inc. · Diabetes Mellitus Type 1 and 2 · Diabetes Mellitus Complications
Phase 1
Completed
20
2016-09
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
Motus Therapeutics, Inc. · Chronic Constipation
Phase 1
Completed
18
2016-09
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
Motus Therapeutics, Inc. · Gastric Motility
Phase 1
Completed
16
2016-09
Search sponsor records
All Motus Therapeutics, Inc. studies.
This page groups studies where Motus Therapeutics, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
7 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT01571297Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic GastroparesisSep 23, 2016NCT01642550Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia NervosaSep 23, 2016NCT01781104Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic ConstipationSep 23, 2016NCT01955616A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic ConstipationSep 23, 2016NCT01394055Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic GastroparesisSep 22, 2016NCT02137642Study to Evaluate the Effects of RM-131 in Patients With Chronic ConstipationSep 22, 2016NCT02466711Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy VolunteersSep 22, 2016